Cambridge, United Kingdom

Nikole Sandy

USPTO Granted Patents = 7 

 

Average Co-Inventor Count = 10.8

ph-index = 4

Forward Citations = 148(Granted Patents)


Company Filing History:


Years Active: 2017-2025

Loading Chart...
Loading Chart...
7 patents (USPTO):Explore Patents

Title: Inventor Profile - Nikole Sandy

Introduction

Nikole Sandy is a prominent inventor based in Cambridge, GB, known for her significant contributions to the field of biotechnology. With a remarkable portfolio of 7 patents, she has established herself as a leading figure in the development of innovative therapies targeting PD-L1, a critical protein implicated in immune responses.

Latest Patents

Among her latest patents, Nikole Sandy's work on anti-PD-L1 antibodies stands out. This invention relates to anti-PD-L1 antibodies, bispecific antibodies containing one domain with specificity to PD-L1, and immunocytokines that comprise an anti-PD-L1 antibody fused to a cytokine such as IL-2. Additionally, the patent includes methods of treatment, applications, and pharmaceutical compositions utilizing these antibodies, bispecific antibodies, and immunocytokines.

Career Highlights

Nikole has worked with several reputable companies in the biopharmaceutical sector. Notably, she has held positions at Kymab Limited and F-star Therapeutics, Inc., where she has advanced the research and development of novel therapeutic solutions.

Collaborations

Throughout her career, Nikole has collaborated with esteemed professionals in her field, including Jamie Iain Campbell and Stephen D Gillies. These collaborations have enabled her to leverage collective expertise and drive innovative research and development initiatives.

Conclusion

Nikole Sandy's extensive work in the realm of antibodies and immunotherapy illustrates her dedication to advancing medical science. Her patented inventions not only highlight her inventive capabilities but also reflect her commitment to improving patient outcomes through innovative biopharmaceuticals.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…